UNIQA Ventures is the venture capital arm of the UNIQA Group, a leading insurance group in its core markets of Austria and Central and Eastern Europe. They invest in exceptional business models driven by strong teams and a clear vision to shape the future of key industries. Our investments focus on late-stage seed and early-stage growth, with a focus on HealthTech, FinTech and InsurTech offerings, as well as relevant enabling technologies (i.e. big data, advanced analytics, blockchain, etc.). vienna
Capricorn Venture Partners is an independent pan-European venture capital firm seeking to invest in technology growth companies. Capricorn’s specialist investment teams are experienced investment managers with deep technology expertise and extensive sector experience. Capricorn currently manages its Capricorn Sustainable Chemistry Fund, Capricorn ICT Arkiv Fund, Capricorn Health-tech Fund and Capricorn Cleantech Fund. Quest for Growth is a management company listed on Euronext Brussels and the investment manager of the Quest Cleantech and Quest+ funds. Leuven
Careventures is an independent pan-European private equity firm that invests in profitable, high-growth small and medium-sized companies in the healthcare sector. Brussels
Imec. xpand is a revolutionary way to invest in early-stage innovation at the intersection of technology transfer, entrepreneurship and traditional venture capital. The fund will extensively leverage the broad technology, knowledge, vision and experience of imec and its strategic investors and will focus on nanoelectronics-based innovation projects in smart applications for a sustainable society, such as smart healthcare, smart mobility, smart cities and smart energy industries. Heverlee
Quest for Growth
Quest for Growth focuses on innovative companies in areas such as digital technology (ICT), health technology and clean technology. Leuven
Smile Invest is an independent European private equity firm that invests in ambitious growth companies. With €350 million in assets, they focus on hidden champions of innovation in target sectors such as software and technology, healthcare and consumer products and services. Our investors are successful entrepreneurs and executives who invest in long-term sustainable value creation. The holding period of our investments is typically 5 years or more. Whether as a minority or majority investor, they partner with profitable, growing companies with a proven track record. They typically invest between EUR 10 million and EUR 50 million or more in companies with revenues of EUR 10 million to EUR 150 million or more.
An early-stage venture capital fund based in Sofia, Bulgaria, that invests in digital start-ups in the South East Europe region. The fund’s portfolio includes companies in SaaS, enterprise software, healthcare technology, e-commerce, mobile technology and IoT, but its investments are not limited to these verticals. With a total of €30m under management, LAUNCHub Ventures focuses on the area of seed investments with investment ticket sizes ranging from €300k to €700k, with the possibility to scale up to €1.5m per company. Sofia
NEVEQ Capital Partners:
The oldest private equity fund manager in Bulgaria and one of the few in Central and Eastern Europe managing more than one private equity fund. Their decades of collective investment experience allow them to invest in enterprise application software, infrastructure software, industry verticals, web and mobile businesses. With their second fund, NEVEQ II, they are also looking at opportunities in other emerging technologies where they can help exceptional entrepreneurs achieve growth and performance, such as healthcare, education and energy efficiency. Luxembourg and Sofia
Credo Ventures is a venture capital firm focused on early-stage investments in Central Europe. Our mission is to find and support the most interesting early stage companies in the region, support them in their growth plans (including expansion into the US or global market) and help them achieve their goals. They look for opportunities to invest in companies with high growth potential, international ambitions and the competence to execute and deliver results. They focus on the IT, Internet and healthcare sectors. Prague
He manages a broad portfolio that includes real estate investments and developments, agriculture and engineering. It also focuses on key sectors of the 21st century: information technology, biotechnology, health food production, renewable energy and life sciences. RSJ Investments is part of the RSJ Group. As our securities trading company, RSJ Securities, they operate in the global financial derivatives markets. Prague
Lifeline Ventures is a Helsinki-based venture capital firm that invests in early-stage healthcare, gaming, web and technology. They were founded by serial entrepreneurs and work with early stage companies on funding, sales, technology, strategy and operations. Lifeline Ventures invests in future category-leading companies with strong founders. To date, they have invested in over 70 companies. Our investment rounds range from EUR 100,000 to EUR 2,000,000 and they participate in angel, seed and Series A rounds. Helsinki
Superhero Capital is to the founders what Alfred is to Batman: behind-the-scenes help. They know what it takes to pursue the seemingly impossible with dogged determination to achieve global success. They have had their share of successes – and occasional failures – to know what it takes to build a company from the ground up. Together, they have founded, worked with and invested in more than 60 startups in a variety of fields, including e-commerce, financial technology, healthcare technology and industrial technology. They are interested in early-stage companies led by passionate founders with big ambitions. They are looking for the next superheroes who strive to take over the world while changing it for the better. Helsinki
Creating and financing health technology start-ups from inception to growth, with the aim of turning innovations into products. Paris
Founded in 1996, Innovation Capital is an international venture capital firm headquartered in Paris with a local office in Silicon Valley. It currently manages more than 450 million euros and focuses on venture and growth investments in innovative healthcare services in Europe. Paris
Founded in July 2009, Kurma Partners is a key European player in the financing of healthcare and biotech innovations, from pre-seed to growth capital, Kurma Partners operates across the entire value chain and has the following activities:Kurma Biofund I is an investment fund focusing on life sciences and healthcare. Its objective is to create a new economic model of innovation financing: a model based on strategic partnerships with the most renowned biotechnology and medical research centres in France and Europe. Kurma Biofund I is particularly interested in early-stage projects, even at the cutting edge of technology, with the aim of turning them into viable business projects and realising them within three to five years. Management of Kurma Biofund II with a target size of EUR 55 million KBII is a venture fund built on the same approach as Kurma Biofund I, with a significant focus on rare diseases (at least 50% of the fund). The four main LPs of the fund are GSK, BPI France, NEA (New Enterprise Associates) and Idinvest Partners. Kurma Diagnostics Fund Management, KDx, first closing of €33 million in May 2015, is an accelerator fund focused exclusively on diagnostic solutions projects and companies (IVD, devices and digital health). KDx builds on the successful investments made in the diagnostics sector during the KBI. The fund benefits from several partnerships with leading European institutions in the field of diagnostics. As part of its advisory mandate, it manages the biotech portfolio of Idinvest Partners, formerly AGF Private Equity (“Idinvest Biotech”). The portfolio included 13 companies, of which 3 have exited and 10 are listed. The total investment amounts to about EUR 100 million. Paris Saclay Seed Fund, Kurma manages the Fund’s investments in the healthcare sector, mainly in diagnostics and digital health. Paris
Founded in 2001, Quadrille Capital is a Paris-based private equity and venture capital firm that invests globally in high-growth technology and healthcare companies backed by leading venture and growth capital funds. The firm manages $1 billion in assets. Quadrille Capital’s unique investment strategy and collaborative approach enables it to partner with the best technology and healthcare funds to access direct investments in some of the world’s most exciting growth companies. Paris
Seventure Partners is Europe’s leading venture capital firm, with over €690 million in assets under management. Since 1997, Seventure Partners has invested in life sciences in Europe, Israel and North America. Its four focus areas are biotechnology and pharmaceuticals, digital/connected healthcare and medical technology, industrial biotechnology and, last but not least, MICROBIOME, nutrition, foodtech and personalised medicine. Investments can range from €500 million to €10 million per round or up to €20 million per company, from early to late stage. Paris
XAnge has been a key investor in Europe for 15 years. With €450 million under management and 55 startups in its portfolio, XAnge is the venture capital arm of the Siparex group. With the growing understanding of human health, rapid technological advances and new trends such as an ageing society, medical and pharmaceutical manufacturers need new technologies to remain effective. They believe that healthcare technology (including IoT), the silver economy and personalised treatment algorithms will solve these challenges.
Ananda Impact Ventures
One of Europe’s leading impact investors. Our investors address societal challenges in vital areas such as education, healthcare, consumption and ageing populations. They believe in the power of market-based, sustainable and scalable models, with positive impact at their core. They share our founders’ passion for creating solutions that make a difference. To support their mission, they have created a space to thrive based on the expertise, network, capital and experience of our team, investors and experts. Ananda manages €80 million across three funds (Social Venture Fund I + II, Ananda Impact Fund). It prides itself on working with some of the leading investors across Europe, from entrepreneurs and families to traditional venture funds.
(DHV) is a sector-focused venture capital fund based in Berlin. They are experienced early-stage investors with several strong European healthcare innovators behind them. Our mission is to build a sustainable digital healthcare ecosystem. They actively support portfolio entrepreneurs and leverage our networks in the technology and healthcare space. Berlin
DvH Ventures: early-stage investment funds investing in Europe’s most passionate founders. With access to Handelsblatt Media Group, Der Tagesspiegel & DIE ZEIT. With a focus on fintech and insurtech and a particular interest in artificial intelligence, cybersecurity, mobile advertising, IoT, big data and digital health, insurance, pensions, education and training, art and culture or real estate and employment. Cologne
Earlybird Venture Capital
Earlybird manages several funds focusing on digital technologies in Eastern and Western Europe and healthcare technologies. With more than €1 billion under management, seven IPOs and 22 deal sales, Earlybird is one of the most successful venture capital firms in Europe. Berlin and Munich
The IONIQ Group is an internationally operating platform company whose mission is to shape Europe’s digital future. In pursuit of this goal, IONIQ advances sector by sector: in 2011, IONIQ started with the data and advertising market, building internationally successful companies such as Zeotap in the process. Since 2014, IONIQ has developed Europe’s leading fintech platform, finleap. Since 2017, IONIQ has been driving the digitalisation of healthcare with its digital health platform Heartbeat Labs. To date, IONIQ Group has created more than 20 companies with over 1,200 employees in more than 10 locations worldwide. IONIQ Group was founded in 2011 as HitFox GmbH by a team consisting of Jan Beckers, Hendrik Krawinkel and Tim Koschella.
Kompass Digital Ventures – Kompass Digital is the venture capital arm of a unique family office focused on investments in financial services, digital health and smart homes. Through early stage investments, they seek to support EU-based digital companies that have the potential to shape industries and expand their reach globally. They are considering leading and co-investing in Financial Services, Digital Health and Smart Home. Berlin
LBBW Venture Capital GmbH
LBBW Venture invests in large entrepreneurs raising a late seed, series A or series B round within the DACH region. They focus on startups within the following three themes: 1. Deep / B2B / EnterpriseTech, 2. FinTech and 3. Initial tickets range between €0.5 and €5 million. They support growth through, for example, LBBW’s broad network of enterprise customers and direct business opportunities for leading FinTechs. Stuttgart
Peppermint Venture Partners
(PVP): a private venture capital firm that invests in early-stage healthcare companies across Europe, focusing on medical devices, digital health and technology platforms. Berlin
Rheingau Founders – Rheingau Founders is a Berlin-based venture capital firm operating since 2011. It focuses on pre-seed to Series A investments in Europe, predominantly B2B in InsurTech, eHealth, Marketplaces, Software as a Service and Building Technologies. Rheingau focuses on start-ups that have the potential to permanently disrupt existing processes and value chains. In addition to financial investments, they offer strategic support through mentoring by our partners. In addition, co-founders can co-found companies if a great idea can be turned into a fast-growing technology company. Berlin
Santo Venture Capital GmbH
A German venture capital fund based in Holzkirchen, Germany. It is a subsidiary of ATHOS Service, the family office of the two pharmaceutical executives Thomas and Andreas Strüngmann, founders of generic drug manufacturer Hexal AG. Founded in 2011, the fund invests in healthcare, biopharma, energy, e-commerce and logistics. It primarily executes Series A and later rounds of financing. Santo Venture Capital Fund’s average investment ranges between €5 and €20 million.
SHS Gesellschaft fur Beteiligungsmanagement
Invest in companies in the healthcare, medical technology, digital health, diagnostics and life sciences sectors in the German-speaking countries (DA-CH), Benelux and Scandinavia. Its investments include venture capital investments in young companies and private equity investments in mid-tier companies. Tübingen
TGFS – Technologiegründerfonds Sachsen
Technologiegründerfonds Sachsen (TGFS) is a regional venture capital company that invests in start-ups and young companies in the high-tech sector based or operating in the federal state of Saxony/Germany. In addition to our extensive network and experience, they support start-ups with investments from 0.1 to 5 million euros. Relevant sectors include ICT (software / industry 4.0 / IoT / big data analytics), semiconductor and microsystems technology, medical technology / health sciences, electronics, sensor technology, new materials, new media and cleantech. Leipzig
Think Health invests as a venture firm in companies in the healthcare sector. They are constantly looking for innovations and disruptive business models in digital health, health technology and healthcare providers. Fürstenfeldbruck
yabeo is a venture investment and advisory firm that invests in early-stage technology companies and grows them sustainably with high impact. yabeo is synonymous with “smart capital”, managed by experienced professionals: successful entrepreneurs, managers and investors who bring their expertise in digital companies focused on FinTech, InsurTech, HealthTech and DeepTech. Our goal is to invest in A and B rounds of technology-driven companies that are making a difference in their segment by redefining the existing rules through new technologies and innovative business models. They educate, connect and leverage innovation ecosystems and networks of startups, growth companies, corporations, founders, technology experts, executives, regulators, universities and leading schools of thought, all with a common interest: to effect change and bring the benefits of digitalisation to the “real” world. Grünwald
It is a venture capital firm investing in Ireland and the UK. Founded in 1994, the firm focuses on investing in early stage technology companies and its team has made over 50 investments in the following sectors. Delta Partners is one of the most active early stage investors in Europe. The partners’ expertise in operations, strategy and finance complements the commitment and ambition of the business management teams. Dublin
Fountain Healthcare Partners
Fountain Healthcare Partners is a life sciences venture capital firm with offices in Dublin, Ireland and New York. Fountain currently manages €175m and is actively investing its second fund raised in July 2014. The Fountain team originally worked within the corporate venture capital group of Elan Corporation and set up its independent fund in 2008. Fountain invests in pharmaceuticals, devices and diagnostics and focuses on companies developing innovative products that address unmet medical needs and offer significant pharmacoeconomic benefits. Dublin
Founded in 2006 with offices in Turin, Milan, Geneva and San Francisco. It manages investment funds totalling approximately €200 million and invests in startups, mainly in the healthcare and digital technology sectors, especially at an early stage; Innogest collaborates with leading local and international research centres and technology transfer offices.
Principia SGR is one of the most prestigious venture and growth capital firms in Italy and has been operating for over a decade. The majority of Principia SGR’s capital is owned by venture and growth capital professionals. Principia SGR currently manages three investment funds. The Principia Fund, focused on investments in the cleantech, biotechnology and information and communication technology sectors, is the first fund launched by SGR. Principia II specialises in investments in the technology and digital innovation sector. Principia III – Health is Italy’s first fund focused on companies in the health sector; it includes venture and growth capital investments. Milan
Fit 4 Start
To maximise the chances of your company’s success and sustainability, Fit 4 Start offers intensive mentoring, attractive seed capital of up to €150,000 and access to the best networks. The programme is open to selected start-ups in the field of ICT, health technology or space with innovative ideas, strong motivation and high growth potential. Luxembourg
NEVEQ Capital Partners
The oldest private equity fund manager in Bulgaria and one of the few in Central and Eastern Europe managing more than one private equity fund. In their ten years of collective investment experience, they have invested in enterprise application software, infrastructure software and industry verticals, as well as web and mobile businesses. With their second fund, NEVEQ II, they are also looking at opportunities in other emerging technologies where they can help exceptional entrepreneurs deliver growth and performance, such as healthcare, education and energy efficiency. Luxembourg and Sofia
Vesalius Biocapital Partners
Vesalius Biocapital Partners invests in human health companies through venture capital funds raised since 2007. Since its creation, they have contributed to the development of 20 companies with more than 150 million euros under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the vast majority of its financing rounds. Their companies are based in Europe, which allows for easy interaction with management. They invest at all stages of development and do not shy away from relatively early-stage projects with reliable proprietary technology and related intellectual property, unique team capabilities and a clear competitive advantage based on solid data.
They are an independent investment firm that invests in inspiring entrepreneurs and their businesses. They help entrepreneurs reach their full potential and achieve healthy, sustainable growth. When they invest, they are fully committed. That’s what they call Committed Capital. Laren
They combine deep market knowledge and industry expertise with a passion for building pioneering businesses and partnering with companies working to solve global health and nutrition challenges. Amsterdam
Gilde Healthcare is a European healthcare investor operating two business lines: a lower middle market buyout fund and a venture and growth capital fund. Gilde Healthcare’s lower middle market buyout fund invests in profitable European healthcare companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare service providers, medical device suppliers and other service providers in the healthcare market. Gilde Healthcare Venture and Growth Capital Fund invests in MedTech, diagnostics, digital health and therapeutics. Portfolio companies are based in Europe and North America. Since 2001, Gilde Healthcare has raised €800 million ($900 million) in its specialised funds. utrecht
Health Innovations invests in young companies that make healthcare better and more accessible. They focus on innovative care concepts, e-health, health technology, digital health and health services. The market is essential for companies to improve healthcare processes: prevention, diagnosis, treatment and follow-up. They invest in the seed and growth phase and our investments must contribute to value creation for the healthcare sector, entrepreneurs and shareholders. As shareholders, they play an active role by leveraging our knowledge, experience and network, but do not take on the role of entrepreneur. Our partnerships typically last between 3 and 8 years. Have you developed a product or service that will improve healthcare and are looking for funding for your company? They invest in young innovative healthcare companies. They would love to talk to you about whether Health Innovations could invest in your company.
NLC – The Healthtech Venture Builder
NLC – the European Healthtech Venture Builder – is dedicated to advancing health, accessibility for all. Our unique NLC approach, using entrepreneurship at scale, enables them to seek out inventions and create and support companies that can reach patients. They are led by winning teams together with a dedicated network and driven by data and information. Amsterdam
Philips Health Technology Ventures
Philips Ventures’ focus areas span the entire spectrum of health, from healthy living to prevention, diagnosis, treatment and home care, and from hardware to services. Amsterdam
Pymwymic – Pymwymic Healthy Ecosystems Impact Fund is a venture capital fund that invests in environmental impact companies that seek to preserve and restore our ecosystems while generating attractive financial returns. Our primary area of focus is on companies that contribute to creating more sustainable food systems. The Healthy Ecosystems Impact Fund is backed by Pymwymic Cooperative, a leading group of private impact investors, and by institutional investors Van Lanschot Kempen and a.s.r. Amsterdam.
Rockstart is an international company that supports and empowers the best startups on their way to success in four areas: Energy, Health, Agriculture & Food and New Technologies. They provide startups with access to capital, market, community and expertise, connecting them with partners, investors, mentors and the wider Rockstart network. Amsterdam
Early stage venture capital firm focused on Europe. They invest in early-stage venture capital funds and direct investments in online and healthcare companies across Europe (and sometimes beyond). They are based in Warsaw and Berlin. Currently, they are almost exclusively interested in genomics-related start-ups. Warsaw
Caixa Capital is the private equity and venture capital fund management company of Caixa Geral de Depósitos, Portugal’s largest banking group with operations in more than 20 countries. Caixa Capital is a pioneer in the Portuguese market, managing EUR 500 million and a total capital of EUR 700 million of potential funds under management. Caixa Capital’s venture capital team works with international funds to support the global expansion of startups associated with Portugal, with team members specialising in ICT, digital technologies, health technologies, engineering and clean technologies. Lisbon
Hovione Capital is a private venture capital firm specialising in the healthcare sector. They invest across Europe in high potential seed/early stage projects in Life Sciences (Therapeutics, MedTech and Digital Health). Lisbon
Alta Life Sciences
Alta Life Sciences is a leading multi-stage venture capital investment firm. Alta LS invests in companies at all stages of development – from seed funding to commercial growth. Alta LS identifies innovative scientific discoveries that address unmet medical needs across the life sciences, including biotechnology, medical devices, diagnostics, genomics and digital health, and invests, seeking both the greatest social impact and the highest potential return. Barcelona
A Barcelona-based venture capital firm that invests in all areas of healthcare. They operate in the medical technology and biopharmaceutical field and seek to invest in highly innovative and transformative technologies in Spain and abroad. They are motivated by the idea of pushing the boundaries of science and medicine. They do this by seeking out and funding the most disruptive technologies and collaborating with the best internal and external talent in our sector. They have an entrepreneurial spirit and strive to participate in building and managing our companies. They are not just investors, but consider themselves partners and collaborators with our portfolio companies. Barcelona
Spanish venture capital and private equity firm specialising in technology investments. With a good knowledge of universities and the technology transfer processes of research and development institutes. They manage 10 investment funds and a broad portfolio of innovative companies in different sectors, with an emphasis on medical technology and healthcare. In the last two years, they have launched four new funds focused on technology transfer, mainly associated with the University of Navarra and the Polytechnic University of Valencia and other health-related research ecosystems.
It is a venture capital firm specialising in technology transfer, investing in startups/spin-offs in the proof-of-concept, seed and start-up phases. Main sectors of activity: agri-food, industrial biotechnology and medical technology. Stages: pre-seed, seed, start-up.
Venture capital fund that invests in start-up and growth-stage companies. They invest in the following sectors: e-commerce, healthcare, technology and education.
Private equity financing for early and mid-stage companies in healthcare and life sciences, specialising in pharmaceuticals, diagnostics and medical devices. Assets under management of €200 million divided into two funds. Barcelona
Although they have media in our DNA, a misconception about them is that they only look for companies with a media affinity. On the contrary, they actively seek high-growth digital and technology companies in sectors such as Marketplaces, B2B, Digital Health and FinTech, among others. Stockholm
HealthCap is a family of venture capital funds investing globally in life sciences. With over €1 billion raised since 1996, HealthCap is one of the largest providers of life sciences venture capital in Europe. HealthCap is a European venture capital firm that invests exclusively and globally in life sciences. The investment strategy focuses on diseases with high levels of unmet medical need and on breakthrough therapies that can be transformative and change medical practice and the lives of patients suffering from these conditions. Since 1996, HealthCap has raised more than EUR 1 billion, backed and built more than 100 companies, taken more than 40 companies public and completed numerous company sales. Stockholm
Invest in founders with a mission in technology and healthcare. Stockholm
Founded in 2006 with offices in Turin, Milan, Geneva and San Francisco. Manages investment funds totalling approximately €200 million and invests in startups mainly in healthcare and digital technology, especially in the early stages – Innogest partners with leading local and international research centres and technology transfer offices.
Amadeus supports entrepreneurs to win. Based on our experience investing in more than 150 companies, they bring the expertise and networks to help entrepreneurs build great businesses from early stage to global growth. They focus on artificial intelligence and machine learning, online consumer services, cybersecurity, digital health and medtech, digital media, enterprise SaaS, fintech, regtech and insurtech. London
Crista Galli Ventures
They invest in ambitious European healthcare technology companies at seed and Series A level. Our deep medical expertise, strong network and agile approach enable the founders to build major world-class healthcare companies. London
Luminous Ventures is the go-to venture fund for the most daring and innovative entrepreneurs in need of seed to series A/B investment. They prefer to be the first venture investor, focusing on visionary founders with breakthrough technologies, backing deep technology and science that matters and delivers the best returns. Backed by a network of families, they lead or follow, investing from €250,000 to €5,000,000. Luminous Ventures is the lead UK investor in the European Institute of Innovation and Technology (EIT). London